|
 The Rennes hospital said in a statement that five other volunteers
were in stable condition after they were admitted last week.
In total, 90 people took part in the trial of the drug made by
Portuguese pharmaceutical company Bial, which is intended to treat
mood and anxiety issues, as well as movement coordination disorders
linked to neurological issues.
It was not yet known what caused the tragedy, said Francois
Peaucelle, the head of Biotrial, the company that conducted the
trials for Bial.
Cases of early-stage clinical trials going badly wrong are rare but
not unheard of. In 2006, six healthy volunteers given an
experimental drug in London ended up in intensive care.
(Reporting by Pierre-Henri Allain; Writing by Leigh Thomas; Editing
by Ros Russell)
[© 2016 Thomson Reuters. All rights
reserved.] Copyright 2016 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed. |
|
